WO2013000277A1 - Method for preparing broad-spectrum long-acting penicillin antibiotic ticarcillin disodium - Google Patents

Method for preparing broad-spectrum long-acting penicillin antibiotic ticarcillin disodium Download PDF

Info

Publication number
WO2013000277A1
WO2013000277A1 PCT/CN2012/000876 CN2012000876W WO2013000277A1 WO 2013000277 A1 WO2013000277 A1 WO 2013000277A1 CN 2012000876 W CN2012000876 W CN 2012000876W WO 2013000277 A1 WO2013000277 A1 WO 2013000277A1
Authority
WO
WIPO (PCT)
Prior art keywords
sodium
ticarcillin
forming agent
ticarcillin disodium
apa
Prior art date
Application number
PCT/CN2012/000876
Other languages
French (fr)
Chinese (zh)
Inventor
隋巍峰
郭顺
刘志
陆祖昆
朱炜
Original Assignee
苏州二叶制药有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 苏州二叶制药有限公司 filed Critical 苏州二叶制药有限公司
Priority to BR112013008592A priority Critical patent/BR112013008592A2/en
Priority to DE112012000225.3T priority patent/DE112012000225B4/en
Publication of WO2013000277A1 publication Critical patent/WO2013000277A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04Preparation
    • C07D499/14Preparation of salts
    • C07D499/16Preparation of salts of alkali or alkaline earth metals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
    • C07D499/58Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
    • C07D499/72Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by carbon atoms having three bonds to hetero atoms

Definitions

  • the invention relates to a preparation method of a broad-spectrum long-acting penicillin antibiotic ticarcillin sodium, and belongs to the technical field of medicine. Background technique
  • Penicillin is extracted from Penicillium culture medium. There are 7 kinds of penicillin G. Penicillin G has the strongest effect, the highest yield and clinical application value. Penicillin G has been used clinically for more than half a century. It is characterized by strong antibacterial action and is used in various cocci and Gram-positive bacteria, but it also has major disadvantages, mainly because it is not resistant to acid, can not be taken orally, and is not resistant to enzymes. Causes drug resistance and narrow spectrum of antibacterial.
  • 6-Aminopenicillanic acid obtained from penicillin fermentation broth, including broad-spectrum long-acting penicillin antibiotics.
  • 6-APA 6-Aminopenicillanic acid
  • Ticardllin Disodium chemical name: ( 2 S,5R, 6 R)-3, 3 _dimethyl-6-[2-carboxy-2-(2-thienyl)acetylamino]-7- Oxo-4-thiazepine Heterobicyclo[3.2.0]heptan-2-carboxylic acid disodium salt)
  • An object of the present invention is to provide a process for preparing ticarcillin sodium which has mild reaction conditions, few side reactions, few steps, and high controllability.
  • ticarcillin is reacted with a salt forming agent to obtain ticarcillin sodium.
  • the salt forming agent is sodium acetate, sodium ethoxide, sodium isooctanoate, sodium isohexanoate, sodium hydrogencarbonate or sodium hydroxide, potassium hydroxide, preferably hydrogen carbonate. sodium.
  • this synthetic route has the following advantages:
  • Ticarcillin (1.35 g, 3.5 mmol) was dissolved in 10 ml of ethyl acetate, and 20 ml of ethyl acetate dissolved in 5 g of sodium hydrogencarbonate was added dropwise thereto, and the mixture was stirred and crystallized at 25 ° C, and dried under reduced pressure at 30 ° C to obtain white crystals. 1.45 g, yield 97%, melting point 201 ° C, HPLC purity: 98.89%, MS (m/z): 429 (M+H)+.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Provided is a method for preparing ticarcillin disodium with less side reaction and strong controllability in mild reaction condition using fewer steps, which comprises (1) reacting 3-thiophene malonic acid with N-hydroxyl succinimide in an organic solvent and under catalysis of DCC and DMAP to obtain an intermediate 1 that is separated and purified by column chromatography, (2) dissolving the intermediate 1 in methylene dichloride and adding 6-APA and an alkali to obtain ticarcillin, and (3) reacting ticarcillin with a salt forming agent to obtain ticarcillin disodium.

Description

广谱长效青霉素类抗生素替卡西林钠的制备方法 技术领域  Preparation method of broad-spectrum long-acting penicillin antibiotic ticarcillin sodium
本发明涉及广谱长效青霉素类抗生素替卡西林钠的制备方法, 属于药物 技术领域。 背景技术  The invention relates to a preparation method of a broad-spectrum long-acting penicillin antibiotic ticarcillin sodium, and belongs to the technical field of medicine. Background technique
青霉素是从青霉菌培养液中提炼得到, 共有 7 种, 其中青霉素 G (Penicillin G) 的作用最强, 产量最高, 有临床应用价值。 青霉素 G在临床 上已应用半个多世纪,其特点是抗菌作用强,用于各种球菌和革兰氏阳性菌, 但也存在较大缺点, 主要是不耐酸、 不能口服、 不耐酶而引起耐药性和抗菌 谱窄。  Penicillin is extracted from Penicillium culture medium. There are 7 kinds of penicillin G. Penicillin G has the strongest effect, the highest yield and clinical application value. Penicillin G has been used clinically for more than half a century. It is characterized by strong antibacterial action and is used in various cocci and Gram-positive bacteria, but it also has major disadvantages, mainly because it is not resistant to acid, can not be taken orally, and is not resistant to enzymes. Causes drug resistance and narrow spectrum of antibacterial.
Figure imgf000002_0001
Figure imgf000002_0001
Penicillin G Penicillin G
Figure imgf000002_0002
Figure imgf000002_0002
6-APA 6-APA
为解决青霉素存在的缺陷,利用从青霉素发酵液中得到的 6-氨基青霉烧 酸 (6-Aminopenicillanic acid, 6-APA)为原料发展了许多半合成青霉素, 其 中包括广谱长效青霉素类抗生素替卡西林钠 (Ticardllin Disodium, 化学名: (2S,5R,6R)-3,3_二甲基 -6-[2-羧基 -2-(2-噻吩基)乙酰氨基] -7-氧代 -4-硫杂小氮 杂双环 [3.2.0]庚垸 -2-羧酸二钠盐) , 结构式为: In order to solve the defects of penicillin, many semi-synthetic penicillins were developed using 6-Aminopenicillanic acid (6-APA) obtained from penicillin fermentation broth, including broad-spectrum long-acting penicillin antibiotics. Ticardllin Disodium, chemical name: ( 2 S,5R, 6 R)-3, 3 _dimethyl-6-[2-carboxy-2-(2-thienyl)acetylamino]-7- Oxo-4-thiazepine Heterobicyclo[3.2.0]heptan-2-carboxylic acid disodium salt), the structural formula is:
Figure imgf000003_0001
替卡西林钠
Figure imgf000003_0001
Ticarcillin sodium
目前通过 6-APA接侧链得到替卡西林钠的合成工艺路线有多种,概括来 说多为对 6-APA或 3-噻吩丙二酸进行羧基或氨基保护后进行縮合反应,然后 对反应产物水解、成盐得到最终产品,通常以三甲基氯硅垸保护 6-APA的氨 基和羧基后,与 3-噻吩基丙二酰氯化物缩合,得中间体 N-三甲基甲硅垸 -6-[ α -氯碳酰基 -2-(3-噻吩基)-乙酰胺 ]-青霉酸三甲基甲硅脂, 水解后, 与 2-乙基己 酸钠成盐, 用乙酸乙酯精制后得最终产品, 此种方法需要先进行基团保护然 后将反应产物再水解, 步骤繁琐, 水解反应不易进行且难于控制。 发明内容  At present, there are various synthetic routes for obtaining ticarcillin sodium through 6-APA side chain. In general, the condensation reaction is carried out after 6-APA or 3-thiophenemalonic acid is protected by carboxyl or amino groups, and then the reaction is carried out. The product is hydrolyzed and salted to obtain a final product. After protecting the amino group and carboxyl group of 6-APA with trimethylsilyl silane, it is condensed with 3-thienylmalonyl chloride to obtain the intermediate N-trimethylsilyl- 6-[ α -Chlorocarbonyl-2-(3-thienyl)-acetamide]-picamic acid trimethylsilyl ester, after hydrolysis, with sodium 2-ethylhexanoate, with ethyl acetate After the refining, the final product is obtained. This method requires first protecting the group and then hydrolyzing the reaction product. The steps are cumbersome, and the hydrolysis reaction is difficult to carry out and difficult to control. Summary of the invention
本发明的目的是提供一种反应条件温和、 副反应少、 步骤少、 可控性强 的替卡西林钠的制备方法。  SUMMARY OF THE INVENTION An object of the present invention is to provide a process for preparing ticarcillin sodium which has mild reaction conditions, few side reactions, few steps, and high controllability.
针对现有技术中对 6-ΑΡΑ或 3-噻吩丙二酸先进行羧基或氨基保护,然后 进行后续反应的技术偏见, 本发明提供一种新的合成方法:  In view of the prior art technical bias for 6- or 3-thiophenemalonic acid prior to carboxyl or amino protection followed by subsequent reactions, the present invention provides a novel synthesis method:
( 1 ) 3-噻吩丙二酸在有机溶剂中, 在 DC (、 DMAP的催化下, 与 N-羟 基琥珀酰亚胺反应得到中间体 1, 经柱层析分离纯化; 所述有机溶剂优选醇 类溶剂, 更优选乙醇;  (1) 3-thiophene malonic acid is reacted with N-hydroxysuccinimide in an organic solvent under the catalysis of DC (by DMAP to obtain intermediate 1, which is purified by column chromatography; the organic solvent is preferably alcohol a solvent-like, more preferably ethanol;
(2) 将中间体 1溶于二氯甲烷中, 加入 6-APA以及碱反应得到替卡西 林; 所述碱是氢氧化钠、 氢氧化钾、 碳酸氢钠、 三乙胺、 二乙胺中的一种, 优选三乙胺;  (2) Dissolving Intermediate 1 in dichloromethane, adding 6-APA and a base to obtain ticarcillin; the base is sodium hydroxide, potassium hydroxide, sodium hydrogencarbonate, triethylamine, diethylamine One type, preferably triethylamine;
(3 ) 替卡西林与成盐剂反应得替卡西林钠, 成盐剂为乙酸钠、 乙醇钠、 异辛酸钠、 异己酸钠、 碳酸氢钠或氢氧化钠、 氢氧化钾, 优选碳酸氢钠。
Figure imgf000004_0001
相对于现有的方法, 该合成路线有如下优点:
(3) ticarcillin is reacted with a salt forming agent to obtain ticarcillin sodium. The salt forming agent is sodium acetate, sodium ethoxide, sodium isooctanoate, sodium isohexanoate, sodium hydrogencarbonate or sodium hydroxide, potassium hydroxide, preferably hydrogen carbonate. sodium.
Figure imgf000004_0001
Compared to existing methods, this synthetic route has the following advantages:
将 3-噻吩丙二酸的一个羧基活化后,直接与 6-APA的氨基反应,无需水 【去除保护基。 反应条件温和、 副反应少、 步骤少、 可控性强。 具体实施方式  After activation of a carboxyl group of 3-thiophene malonic acid, it directly reacts with the amino group of 6-APA without water [removing the protecting group. The reaction conditions are mild, the side reactions are few, the steps are small, and the controllability is strong. detailed description
现通过以下实施例来进一步描述本发明的有益效果, 应理解为这些实施 例仅用于例证的目的, 不限制本发明的范围, 同时本领域技术人员根据本发 明所做的显而易见的改变和修饰也包含在本发明的范围内。 实施例 1:  The invention is further described by the following examples, which are intended to be illustrative only and not to limit the scope of the invention, and obvious modifications and It is also included in the scope of the invention. Example 1:
将 3-噻吩丙二酸(0.74g,4.0mmol)溶于 10ml乙醇中,加入 DMAP(730mg, 6mmol) 和 DCC ( 1.2g, 6.0mmol) 室温搅拌半小时后, 加入 N-羟基琥珀酰 亚胺 (0.47g, 4mmol) , 室温搅拌半小时后, 加入饱和 Ν¾( 溶液搅拌后, 乙酸乙酯萃取, 分出乙酸乙酯层,有机相经饱和食盐水洗,无水硫酸钠干燥, 蒸除溶剂, 柱层析 (乙酸乙酯 /甲醇 =10: 1 )洗脱, 得到中间体 1 1.05g, 收 率 93%。  3-The thiophene malonic acid (0.74 g, 4.0 mmol) was dissolved in 10 ml of ethanol, and DMAP (730 mg, 6 mmol) and DCC (1.2 g, 6.0 mmol) were added and stirred at room temperature for half an hour, then N-hydroxysuccinimide was added. (0.47g, 4mmol), after stirring at room temperature for half an hour, and then added to a saturated solution of EtOAc (EtOAc). Column chromatography (ethyl acetate / methanol = 10:1) eluted to afford Intermediate 1 1.05 g, yield 93%.
将中间体 1 ( 1.05g, 3.7mmol)溶于 20ml二氯甲烷中,加入 6-APA (0.8g, 3.7mmol)和三乙胺 10ml室温搅拌反应 8小时后, 用 lmol/1的盐酸溶液调酸 性(PH=2.0) , 并在 -5°C下反应 2h。 二氯甲垸萃取, 活性炭脱色, 干燥后浓 缩得替卡西林 1.35g, 收率 95%, MS(m/z):385(M+H)+。 将替卡西林(1.35g, 3.5mmol) 溶于 10ml乙酸乙酯中, 滴入溶有 5g碳酸氢钠的乙酸乙酯 20ml, 25°C搅拌析晶, 30°C减压烘干得到白色晶体 1.45g, 收率 97%, 熔点 201 °C, HPLC检测纯度为 98.89%, MS(m/z):429(M+H)+。 Intermediate 1 (1.05 g, 3.7 mmol) was dissolved in 20 ml of dichloromethane, and 6-APA (0.8 g, 3.7 mmol) and triethylamine 10 ml were added and stirred at room temperature for 8 hours, then adjusted with 1 mol/l hydrochloric acid solution. Acidic (pH = 2.0) and reacted at -5 °C for 2 h. Extraction of dichloromethane, decolorization of activated carbon, thickening after drying 1.37 g of ticarcillin was obtained, yield 95%, MS (m/z): 385 (M+H)+. Ticarcillin (1.35 g, 3.5 mmol) was dissolved in 10 ml of ethyl acetate, and 20 ml of ethyl acetate dissolved in 5 g of sodium hydrogencarbonate was added dropwise thereto, and the mixture was stirred and crystallized at 25 ° C, and dried under reduced pressure at 30 ° C to obtain white crystals. 1.45 g, yield 97%, melting point 201 ° C, HPLC purity: 98.89%, MS (m/z): 429 (M+H)+.

Claims

权 利 要 求 书 Claim
1. 替卡西林钠的制备方法, 包括以下步骤: 1. A method for preparing ticarcillin sodium, comprising the steps of:
( 1 ) 3-噻吩丙二酸在有机溶剂中, 在 DC 、 DMAP的催化下, 与 N-羟 基琥珀酰亚胺反应得到中间体, 经柱层析分离纯化;  (1) 3-thiophene malonic acid is reacted with N-hydroxysuccinimide in an organic solvent under the catalysis of DC and DMAP to obtain an intermediate, which is separated and purified by column chromatography;
(2)将中间体溶于二氯甲烷中,加入 6-APA以及碱反应得到替卡西林; (2) dissolving the intermediate in dichloromethane, adding 6-APA and a base to obtain ticarcillin;
(3 ) 替卡西林与成盐剂反应得替卡西林钠。 (3) ticarcillin is reacted with a salt forming agent to obtain ticarcillin sodium.
2.根据权利要求 1所述的方法, 其特征在于, 步骤 (1 ) 所述有机溶剂 为醇类溶剂。  The method according to claim 1, wherein the organic solvent is an alcohol solvent.
3. 根据权利要求 2所述的方法, 其特征在于, 所述醇类溶剂为乙醇。  3. The method according to claim 2, wherein the alcohol solvent is ethanol.
4.根据权利要求 1所述的方法, 其特征在于, 步骤 (2) 所述碱是氢氧 化钠、 氢氧化钾、 碳酸氢钠、 三乙胺、 二乙胺中的一种。  The method according to claim 1, wherein the base (2) is one of sodium hydroxide, potassium hydroxide, sodium hydrogencarbonate, triethylamine, and diethylamine.
5. 根据权利要求 4所述的方法, 其特征在于, 所述碱为三乙胺。  5. Method according to claim 4, characterized in that the base is triethylamine.
6.根据权利要求 1所述的方法, 其特征在于, 步骤 (3 ) 所述成盐剂为 乙酸钠、 乙醇钠、 异辛酸钠、 异己酸钠、 碳酸氢钠或氢氧化钠、 氢氧化钾。  The method according to claim 1, wherein the salt forming agent is sodium acetate, sodium ethoxide, sodium isooctanoate, sodium isohexanoate, sodium hydrogencarbonate or sodium hydroxide, potassium hydroxide. .
7. 根据权利要求 6所述的方法, 其特征在于, 所述成盐剂为碳酸氢钠。  7. The method according to claim 6, wherein the salt forming agent is sodium hydrogencarbonate.
PCT/CN2012/000876 2011-06-28 2012-06-27 Method for preparing broad-spectrum long-acting penicillin antibiotic ticarcillin disodium WO2013000277A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR112013008592A BR112013008592A2 (en) 2011-06-28 2012-06-27 method for preparing a broad-spectrum long-acting penicillin disodium ticarcillin antibiotic
DE112012000225.3T DE112012000225B4 (en) 2011-06-28 2012-06-27 Process for producing long-acting penicillin broad spectrum antibiotic ticarcillin disodium

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201110175843.1 2011-06-28
CN 201110175843 CN102268017B (en) 2011-06-28 2011-06-28 Preparation method of broad-spectrum long-acting penicillin antibiotic ticarcillin sodium

Publications (1)

Publication Number Publication Date
WO2013000277A1 true WO2013000277A1 (en) 2013-01-03

Family

ID=45050494

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2012/000876 WO2013000277A1 (en) 2011-06-28 2012-06-27 Method for preparing broad-spectrum long-acting penicillin antibiotic ticarcillin disodium

Country Status (4)

Country Link
CN (1) CN102268017B (en)
BR (1) BR112013008592A2 (en)
DE (1) DE112012000225B4 (en)
WO (1) WO2013000277A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108727593A (en) * 2018-06-15 2018-11-02 张礼国 A kind of antimicrobial organosilane glue material and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101735244A (en) * 2008-11-05 2010-06-16 鲁南制药集团股份有限公司 Method for preparing broad-spectrum penicillin antibiotic ticarcillin sodium
CN101875659A (en) * 2009-04-29 2010-11-03 瑞阳制药有限公司 Preparation process of ticarcillin disodium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1538051A (en) * 1975-01-17 1979-01-10 Beecham Group Ltd 6-methoxy-6-(alpha-carboxyacetamido)-penicillins
GB1579362A (en) * 1977-03-16 1980-11-19 Beecham Group Ltd 6-(a-heterocyclylcarbonyl amino-acetamido)-penicillins and compositions containing them
DE2921422C2 (en) * 1978-12-18 1985-04-18 Bristol-Myers Co., New York, N.Y. Intermediate products for the manufacture of penicillins and their use, processes for the manufacture of the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101735244A (en) * 2008-11-05 2010-06-16 鲁南制药集团股份有限公司 Method for preparing broad-spectrum penicillin antibiotic ticarcillin sodium
CN101875659A (en) * 2009-04-29 2010-11-03 瑞阳制药有限公司 Preparation process of ticarcillin disodium

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Kirk-Othmer Encyclopedia of Chemical Technology", December 2000, article R. J. PONSFORD ET AL.: "Penicillins and others, Beta-Lactams", pages: 1 - 25 *

Also Published As

Publication number Publication date
CN102268017A (en) 2011-12-07
DE112012000225B4 (en) 2014-07-10
CN102268017B (en) 2012-11-28
DE112012000225T5 (en) 2013-08-22
BR112013008592A2 (en) 2017-10-31

Similar Documents

Publication Publication Date Title
CN101319246B (en) Process for preparing cefixime
US20140018577A1 (en) Process for Preparing Lacosamide
CN114478690B (en) Preparation method of 6, 6-dimethyl-3-azabicyclo [3.1.0] hexane derivative
CN101941969A (en) Preparation method of moxifloxacin hydrochloride
CN104130258A (en) Conversion method for dimers
CN110981779B (en) Synthesis method of R-2- (2, 5-difluorophenyl) pyrrolidine
WO2018207111A1 (en) A process for the preparation of sglt2 inhibitors and intermediates thereof
CN114634441A (en) Novel method for synthesizing 6, 6-dimethyl-3-azabicyclo [3,1,0] hexane
CN103897025B (en) A kind of preparation method of Pidotimod
CN102659817B (en) Preparation method of cefdinir
CN101575298B (en) Method for preparing chiral medicinal intermediate 2-amido-1-phenylethylalcohol
CN110128449B (en) 7-phenylacetamido-3-deacetoxy cephalosporanic acid salt and preparation method and application thereof
WO2013000277A1 (en) Method for preparing broad-spectrum long-acting penicillin antibiotic ticarcillin disodium
CN104045655A (en) Synthesis method of antibiotic cephalosporin mother nucleus
CN106279207A (en) A kind of synthetic method of cefdinir
CN103044416A (en) Synthetic method of Carumonam sodium
CN111072547A (en) Chemical preparation method of 2-azabicyclo [2.2.1] hept-5-ene-3-ketone with optical activity
JP2010043053A (en) Process for producing high purity rebamipide
CN110684039B (en) Preparation method of cefoxitin lactone
CN108033972B (en) Synthesis method of cefprozil
CN105218562A (en) A kind of preparation method of D (-)-Sulfocillin
CN107324998B (en) Method for preparing external antibiotic drug Retapamulin
CN109400630B (en) Synthetic method of flucloxacillin sodium
CN104230955A (en) Preparation method of p-hydroxy penicillin V acid and salt thereof
WO2014128538A1 (en) A process for the preparation of amoxicillin trihydrate

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12803706

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 112012000225

Country of ref document: DE

Ref document number: 1120120002253

Country of ref document: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013008592

Country of ref document: BR

122 Ep: pct application non-entry in european phase

Ref document number: 12803706

Country of ref document: EP

Kind code of ref document: A1

REG Reference to national code

Ref country code: BR

Ref legal event code: B01E

Ref document number: 112013008592

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013008592

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20130409